Akero Therapeutics has a solid cash runway and financial stability to support ongoing trials for its drug candidate. Read ...

This post was written by Melanie Riehl BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best biotech plays outside of the GLP-1 ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Check the time stamp on this data. Updated AI-Generated Signals for Global Partners Lp Representing Limited Partner Interests ...